Palatin Technologies, Inc. AMEX:PTN

Founder-led company

Palatin Technologies stock price today

$0.094
-1.01
-91.52%
Financial Health
0
1
2
3
4
5
6
7
8
9

Palatin Technologies stock price monthly change

-37.29%
month

Palatin Technologies stock price quarterly change

-37.29%
quarter

Palatin Technologies stock price yearly change

-71.61%
year

Palatin Technologies key metrics

Market Cap
19.78M
Enterprise value
8.14M
P/E
-0.83
EV/Sales
2.68
EV/EBITDA
-0.25
Price/Sales
9.34
Price/Book
1.73
PEG ratio
0.12
EPS
-3.38
Revenue
N/A
EBITDA
-39.05M
Income
-38.91M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-1380%
Oper. margin
-1055.88%
Gross margin
89.08%
EBIT margin
-1055.88%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Palatin Technologies stock price history

Palatin Technologies stock forecast

Palatin Technologies financial statements

Palatin Technologies, Inc. (AMEX:PTN): Profit margin
Jun 2022 770.73K -12.76M -1656.54%
Mar 2023 1.19M -6.99M -585.28%
Jun 2023 1.76M -10.71M -608.11%
Mar 2024 0 -8.43M
Palatin Technologies, Inc. (AMEX:PTN): Analyst Estimates
2028 111.29M 5.66M 5.09%
  • Analysts Price target

  • Financials & Ratios estimates

Palatin Technologies, Inc. (AMEX:PTN): Debt to assets
Dec 2022 31976538 15.63M 48.89%
Mar 2023 25608896 16.01M 62.54%
Jun 2023 17939440 15.72M 87.64%
Mar 2024 11406237 9.82M 86.16%
Palatin Technologies, Inc. (AMEX:PTN): Cash Flow
Jun 2022 -7.71M -37.11K -24.41K
Mar 2023 -1.40M -116.87K -25.31K
Jun 2023 -9.60M -3.04M 1.00M
Mar 2024 -8.60M 0 9.13M

Palatin Technologies alternative data

Palatin Technologies, Inc. (AMEX:PTN): Employee count
Aug 2023 33
Sep 2023 33
Oct 2023 33
Nov 2023 34
Dec 2023 34
Jan 2024 34
Feb 2024 34
Mar 2024 34
Apr 2024 34
May 2024 34
Jun 2024 34
Jul 2024 34

Palatin Technologies other data

0.14% -0.62%
of PTN is owned by hedge funds
318.11K -1.45M
shares is hold by hedge funds

Palatin Technologies, Inc. (AMEX:PTN): Insider trades (number of shares)
Period Buy Sel
Dec 2023 0 5198
Mar 2024 0 11700
Apr 2024 6000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
DEVEER ROBERT K JR director
Common Stock 6,000 $2.12 $12,702
Sale
DEVEER ROBERT K JR director
Common Stock 1,685 $2 $3,370
Sale
DEVEER ROBERT K JR director
Common Stock 7,486 $2 $14,972
Sale
DEVEER ROBERT K JR director
Common Stock 1,808 $2.01 $3,634
Sale
DEVEER ROBERT K JR director
Common Stock 106 $2.01 $213
Sale
DEVEER ROBERT K JR director
Common Stock 460 $2.02 $929
Sale
DEVEER ROBERT K JR director
Common Stock 155 $2.03 $315
Sale
WILLS STEPHEN T officer: Executive VP and CFO/COO
Common Stock 2,807 $2.42 $6,779
Sale
WILLS STEPHEN T officer: Executive VP and CFO/COO
Common Stock 2,191 $2.64 $5,784
Sale
DUNTON ALAN W director
Common Stock 199 $2.48 $494
Insider Compensation
Dr. Carl Spana Ph.D. (1962) Co-Founder, Pres, Chief Executive Officer & Director $924,500
Mr. Stephen T. Wills CPA, CPA, MST (1957) Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer & Sec.
$851,930
Thursday, 19 December 2024
prnewswire.com
Monday, 16 December 2024
prnewswire.com
Monday, 25 November 2024
prnewswire.com
Thursday, 14 November 2024
seekingalpha.com
prnewswire.com
Friday, 8 November 2024
prnewswire.com
Monday, 4 November 2024
prnewswire.com
Thursday, 31 October 2024
prnewswire.com
Thursday, 24 October 2024
prnewswire.com
Wednesday, 23 October 2024
prnewswire.com
Monday, 7 October 2024
prnewswire.com
Tuesday, 1 October 2024
prnewswire.com
Thursday, 26 September 2024
prnewswire.com
Monday, 9 September 2024
prnewswire.com
Wednesday, 28 August 2024
prnewswire.com
Thursday, 22 August 2024
prnewswire.com
Friday, 21 June 2024
prnewswire.com
Thursday, 20 June 2024
prnewswire.com
Wednesday, 12 June 2024
prnewswire.com
Monday, 20 May 2024
https://www.benzinga.com
zacks.com
Wednesday, 15 May 2024
prnewswire.com
Thursday, 9 May 2024
PRNewsWire
Tuesday, 9 April 2024
Zacks Investment Research
Thursday, 15 February 2024
InvestorPlace
Friday, 9 February 2024
PRNewsWire
Thursday, 1 February 2024
InvestorPlace
Thursday, 11 January 2024
InvestorPlace
Saturday, 23 December 2023
InvestorPlace
Thursday, 9 November 2023
PRNewsWire
  • What's the price of Palatin Technologies stock today?

    One share of Palatin Technologies stock can currently be purchased for approximately $0.09.

  • When is Palatin Technologies's next earnings date?

    Unfortunately, Palatin Technologies's (PTN) next earnings date is currently unknown.

  • Does Palatin Technologies pay dividends?

    No, Palatin Technologies does not pay dividends.

  • How much money does Palatin Technologies make?

    Palatin Technologies has a market capitalization of 19.78M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 7.49% to 4.49M US dollars.

  • What is Palatin Technologies's stock symbol?

    Palatin Technologies, Inc. is traded on the AMEX under the ticker symbol "PTN".

  • What is Palatin Technologies's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Palatin Technologies?

    Shares of Palatin Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Palatin Technologies's key executives?

    Palatin Technologies's management team includes the following people:

    • Dr. Carl Spana Ph.D. Co-Founder, Pres, Chief Executive Officer & Director(age: 63, pay: $924,500)
    • Mr. Stephen T. Wills CPA, CPA, MST Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer & Sec.(age: 68, pay: $851,930)
  • Is Palatin Technologies founder-led company?

    Yes, Palatin Technologies is a company led by its founder Dr. Carl Spana Ph.D..

  • How many employees does Palatin Technologies have?

    As Jul 2024, Palatin Technologies employs 34 workers.

  • When Palatin Technologies went public?

    Palatin Technologies, Inc. is publicly traded company for more then 27 years since IPO on 15 Oct 1997.

  • What is Palatin Technologies's official website?

    The official website for Palatin Technologies is palatin.com.

  • Where are Palatin Technologies's headquarters?

    Palatin Technologies is headquartered at Cedar Brook Corporate Center, Cranbury, NJ.

  • How can i contact Palatin Technologies?

    Palatin Technologies's mailing address is Cedar Brook Corporate Center, Cranbury, NJ and company can be reached via phone at +60 9 495 2200.

Palatin Technologies company profile:

Palatin Technologies, Inc.

palatin.com
Exchange:

AMEX

Full time employees:

30

Industry:

Biotechnology

Sector:

Healthcare

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.

Cedar Brook Corporate Center
Cranbury, NJ 08512

CIK: 0000911216
ISIN: US6960775020
CUSIP: 696077403